Curative Biotechnology (OTCMKTS:CUBTD) Shares Gap Down – Should You Sell?

Shares of Curative Biotechnology, Inc. (OTCMKTS:CUBTD) gapped down before the market opened on Wednesday . The stock had previously closed at $1.10, but opened at $1.05. Curative Biotechnology shares last traded at $1.05, with a volume of 100 shares.

Curative Biotechnology Price Performance

The firm has a 50-day moving average of $0.03 and a two-hundred day moving average of $0.01.

Curative Biotechnology Company Profile

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc to develop the COVID-19 vaccine.